NFKB1 and colorectal cancer: In colorectal cancer, the inflammatory mediator prostaglandin E2 activates NF‐κB through prostaglandin E Receptor 4‐phosphoinositide 3‐kinase to promote the formation, maintenance, and metastasis of CSCs.361